Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes.

Martis S, Peter I, Hulot JS, Kornreich R, Desnick RJ, Scott SA.

Pharmacogenomics J. 2013 Aug;13(4):369-77. doi: 10.1038/tpj.2012.10. Epub 2012 Apr 10.

2.

Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians.

Suarez-Kurtz G, Genro JP, de Moraes MO, Ojopi EB, Pena SD, Perini JA, Ribeiro-dos-Santos A, Romano-Silva MA, Santana I, Struchiner CJ.

Pharmacogenomics J. 2012 Jun;12(3):267-76. doi: 10.1038/tpj.2010.89. Epub 2010 Dec 21.

PMID:
21173785
3.

Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations.

Pedersen RS, Brasch-Andersen C, Sim SC, Bergmann TK, Halling J, Petersen MS, Weihe P, Edvardsen H, Kristensen VN, Brøsen K, Ingelman-Sundberg M.

Eur J Clin Pharmacol. 2010 Dec;66(12):1199-205. doi: 10.1007/s00228-010-0864-8. Epub 2010 Jul 28.

PMID:
20665013
4.

Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population.

Kudzi W, Dodoo AN, Mills JJ.

BMC Med Genet. 2009 Dec 2;10:124. doi: 10.1186/1471-2350-10-124.

5.

Similarity in recombination rate and linkage disequilibrium at CYP2C and CYP2D cytochrome P450 gene regions among Europeans indicates signs of selection and no advantage of using tagSNPs in population isolates.

Pimenoff VN, Laval G, Comas D, Palo JU, Gut I, Cann H, Excoffier L, Sajantila A.

Pharmacogenet Genomics. 2012 Dec;22(12):846-57. doi: 10.1097/FPC.0b013e32835a3a6d.

PMID:
23089684
6.

Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population.

Hamdy SI, Hiratsuka M, Narahara K, El-Enany M, Moursi N, Ahmed MS, Mizugaki M.

Br J Clin Pharmacol. 2002 Jun;53(6):596-603.

7.

CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.

Scott SA, Edelmann L, Kornreich R, Erazo M, Desnick RJ.

Pharmacogenomics. 2007 Jul;8(7):721-30. doi: 10.2217/14622416.8.7.721.

PMID:
18240905
8.
9.

Genetic variants in CYP (-1A2, -2C9, -2C19, -3A4 and -3A5), VKORC1 and ABCB1 genes in a black South African population: a window into diversity.

Dandara C, Lombard Z, Du Plooy I, McLellan T, Norris SA, Ramsay M.

Pharmacogenomics. 2011 Dec;12(12):1663-70. doi: 10.2217/pgs.11.106.

10.

Distribution of CYP2C9*13 allele in the Chinese Han and the long-range haplotype containing CYP2C9*13 and CYP2C19*2.

Si D, Wang J, Zhang Y, Zhong D, Zhou H.

Biopharm Drug Dispos. 2012 Sep;33(6):342-5. doi: 10.1002/bdd.1804.

PMID:
22886551
11.

CYP2C9 allelic variants: ethnic distribution and functional significance.

Xie HG, Prasad HC, Kim RB, Stein CM.

Adv Drug Deliv Rev. 2002 Nov 18;54(10):1257-70. Review.

PMID:
12406644
12.

Inactive alleles of cytochrome P450 2C19 may be positively selected in human evolution.

Janha RE, Worwui A, Linton KJ, Shaheen SO, Sisay-Joof F, Walton RT.

BMC Evol Biol. 2014 Apr 1;14:71. doi: 10.1186/1471-2148-14-71.

13.

Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups.

Scott SA, Khasawneh R, Peter I, Kornreich R, Desnick RJ.

Pharmacogenomics. 2010 Jun;11(6):781-91. doi: 10.2217/pgs.10.49.

14.

CYP2C9 and CYP2C19 Allele and Haplotype Distributions in Four Mestizo Populations from Western Mexico: An Interethnic Comparative Study.

Saldaña-Cruz AM, León-Moreno LC, Sánchez-Corona J, Santiago DA, Mendoza-Carrera F, Castro-Martínez XH, García-Zapién AG, Morán-Moguel MC, Flores-Martínez SE.

Genet Test Mol Biomarkers. 2016 Nov;20(11):702-709. Epub 2016 Sep 12.

PMID:
27617498
15.

Distribution of polymorphisms in the CYP2C9 gene and CYP2C19/CYP2C9 haplotypes among Venezuelan populations.

Flores-Gutiérrez S, Rodríguez-Larralde Á, Vívenes de Lugo M, Castro de Guerra D.

Ann Hum Biol. 2017 Mar;44(2):191-198. doi: 10.1080/03014460.2016.1192218. Epub 2016 Jun 13.

PMID:
27230833
16.

Distribution of CYP2C19*17 allele and genotypes in an Indian population.

Anichavezhi D, Chakradhara Rao US, Shewade DG, Krishnamoorthy R, Adithan C.

J Clin Pharm Ther. 2012 Jun;37(3):313-8. doi: 10.1111/j.1365-2710.2011.01294.x. Epub 2011 Sep 15.

PMID:
21916910
17.

Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese.

Zhou Q, Yu XM, Lin HB, Wang L, Yun QZ, Hu SN, Wang DM.

Pharmacogenomics J. 2009 Dec;9(6):380-94. doi: 10.1038/tpj.2009.31. Epub 2009 Jul 28.

PMID:
19636337
18.

CYP2C8 polymorphism among the Portuguese.

Cavaco I, Piedade R, Gil JP, Ribeiro V.

Clin Chem Lab Med. 2006;44(2):168-70.

PMID:
16475901
19.

Identification of CYP2C19*4B: pharmacogenetic implications for drug metabolism including clopidogrel responsiveness.

Scott SA, Martis S, Peter I, Kasai Y, Kornreich R, Desnick RJ.

Pharmacogenomics J. 2012 Aug;12(4):297-305. doi: 10.1038/tpj.2011.5. Epub 2011 Mar 1.

Supplemental Content

Support Center